Oruka Therapeutics Announces Positive Interim Phase 1 Results for ORKA-001

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/26/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. AWK
8. DRI
9. ULS
10. PRME

Go back to Oruka Therapeutics Announces Positive Interim Phase 1 Results for ORKA-001
(NASDAQ: ORKA) Delayed: 84.46 -1.03 (1.2%)
Previous Close $85.49    52 Week High $ 
Open $86.49    52 Week Low $ 
Day High $86.49    P/E N/A 
Day Low $84.00    EPS $ 
Volume 499,723